Tod Smeal - 07 Mar 2024 Form 4 Insider Report for Cardiff Oncology, Inc. (CRDF)

Role
Chief Scientific Officer
Signature
/s/ Tod Smeal
Issuer symbol
CRDF
Transactions as of
07 Mar 2024
Net transactions value
$0
Form type
4
Filing time
07 Mar 2024, 18:39:51 UTC
Previous filing
16 Mar 2023
Next filing
13 Mar 2025
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CRDF Stock Options Award $0 +205,008 +46% $0.000000 647,184 07 Mar 2024 Common Stock 205,008 $3.51 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 25% of the shares subject to the option will vest on March 7, 2025 and the remaining shares vest in 36 equal monthly installments thereafter, subject to the continued service of the reporting person.